Computed Tomography Appearance of Early Radiation Injury to the Lung: Correlation with Clinical and Dosimetric Factors
Overview
Authors
Affiliations
Purpose: To systematically assess the spectrum of radiologic changes in the lung after radiation therapy for non-small-cell lung cancer.
Methods And Materials: We reviewed the cases of 146 patients treated with radical radiotherapy at our institution. All patients had computed tomography (CT) scans performed 3 months after completion of therapy. Radiographic appearances were categorized using a standard grading system. The association of these abnormalities with pretreatment factors and clinical radiation pneumonitis (RP) was investigated.
Results: New intrapulmonary abnormalities were seen in 92 patients (63%). These were ground-glass opacity in 16 (11%), patchy consolidation in 19 (13%), and diffuse consolidation in 57 (39%). Twenty-five patients (17%) developed clinical symptoms of RP. Although 80% of the patients with RP had areas of consolidation seen on the posttreatment CT scan, the majority (74%) of patients with such radiographic changes were asymptomatic. For patients with lung infiltrates, the minimum isodose encompassing the volume of radiologic abnormality was usually ≥27 Gy. Traditional dose-volume metrics, pulmonary function tests, and the coadministration of angiotensin converting enzyme inhibitors (ACE-I) were all strongly correlated with the presence of radiologic injury on univariate analysis (p≤0.002). There was also an inverse correlation between prior smoking history and CT scan changes (p=0.02). On multivariate analysis, dosimetric parameters and the use of ACE-I retained significance (p=0.005).
Conclusions: Our findings suggest that there is substantial interindividual variation in lung radiosensitivity. ACE-I prevented the radiologic changes seen after high-dose radiation therapy, and their role as radioprotectants warrants further investigation.
Liao W, Shokr H, Faivre-Finn C, Dempsey C, Williams K, Chen L Pharmaceuticals (Basel). 2025; 18(1).
PMID: 39861167 PMC: 11769270. DOI: 10.3390/ph18010105.
Cao Y, Zhang S, Tang L, Chen Y, Jiang S, Liu L Heliyon. 2023; 9(9):e19949.
PMID: 37810141 PMC: 10559567. DOI: 10.1016/j.heliyon.2023.e19949.
Masuoka Y, Tada T, Tokunaga M, Takeshita N, Terashima M, Tsutsumi S Nagoya J Med Sci. 2022; 84(1):180-184.
PMID: 35392013 PMC: 8971034. DOI: 10.18999/nagjms.84.1.180.
Radiation-Induced Lung Injury-Current Perspectives and Management.
Rahi M, Parekh J, Pednekar P, Parmar G, Abraham S, Nasir S Clin Pract. 2021; 11(3):410-429.
PMID: 34287252 PMC: 8293129. DOI: 10.3390/clinpract11030056.
Szejniuk W, Nielsen M, Takacs-Szabo Z, Pawlowski J, Al-Saadi S, Maidas P Radiat Oncol. 2021; 16(1):131.
PMID: 34266462 PMC: 8281688. DOI: 10.1186/s13014-021-01857-8.